In its first meeting, a carefully chosen advisory committee of experts on gene editing under the World Health Organization this week agreed on the immediate need for a global registry of research that funders should make binding for researchers. The group acknowledged an urgency in addressing human gene editing governance in light of work already taking place, but stopped short of calling for a moratorium at this time, instead issuing a statement that it would be "irresponsible" for anyone to proceed with such research now. Continue reading ->
There continues to be positive progress on controlling the use of antimicrobials in animals in countries, according to a recent report of the World Organisation for Animal Health (OIE), which is linked to the rise in human antimicrobial resistance. But more countries need to take action and better data is needed from many, the report found, as efforts will continue. Continue reading ->
Registration has begun for a closed-door gathering allowing governments and stakeholders to hold open discussions about a fairer pricing system for medical products, led by the World Health Organization. The second meeting of the Fair Pricing Forum, this time in South Africa, comes as debates over drug pricing and access rise ever higher in developing and developed countries alike. Continue reading ->
A network of life sciences organisations working together to address antibacterial resistance worldwide has expanded to now include 10 top organisations from six countries, according to CARB-X (Combating Antibiotic Resistant Bacteria), a US-based partnership investing hundreds of millions of dollars in R&D for antibacterial resistance over 5 years. Continue reading ->